Cadrenal Therapeutics, Inc. (CVKD)
NASDAQ: CVKD · Real-Time Price · USD
11.29
-0.58 (-4.89%)
At close: Jul 18, 2025, 4:00 PM
11.14
-0.15 (-1.33%)
After-hours: Jul 18, 2025, 6:53 PM EDT

Cadrenal Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22
222610-
Market Cap Growth
239.36%168.05%--
Enterprise Value
15211-
Last Close Price
11.2914.4911.10-
PB Ratio
3.533.471.25-
P/TBV Ratio
3.633.471.25-
Debt / Equity Ratio
--0.00-0.11
Quick Ratio
4.003.7510.210.02
Current Ratio
4.323.7710.270.55
Return on Equity (ROE)
-208.59%-140.78%-780.59%-
Return on Assets (ROA)
-109.43%-73.49%-102.62%-
Return on Capital (ROIC)
-133.24%-90.41%-340.35%-
Earnings Yield
-57.80%-41.24%-86.73%-
FCF Yield
-45.85%-28.51%-36.67%-
Buyback Yield / Dilution
-43.28%-35.59%-70.99%-
Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q